In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris

In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris

Introduction: Clopidogrel is a potent platelet activation and aggregation inhibitor that prevents thrombosis in coronary artery diseases (CADs). In comparison to locally produced generic one (Osvix®), original brand of clopidogrel (Plavix®) is expensive. This study was designed to evaluate the effec...

Full description

Bibliographic Details
Main Authors: Rza Hajizadeh, Samad Ghaffari, Mojtaba Ziaee, Behrooz Shokouhi, Ahmad Separham, Parvin Sarbakhsh
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2017-12-01
Series:Journal of Cardiovascular and Thoracic Research
Subjects:
stable angina
clopidogrel
generic
brand
platelet aggregation
Online Access:https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-9-191.pdf

Internet

https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-9-191.pdf

Similar Items